Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...
(HSIC) stock saw a modest uptick, ending the day at $79.87 which represents a slight increase of $3.77 or 4.95% from the prior close of $76.1. The stock opened at $77.5 and touched a low of $77.5 ...
Mizuho analyst Steven Valiquette raised the firm’s price target on Henry Schein (HSIC) to $78 from $75 and keeps a Neutral rating on the ...
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...
Henry Schein Inc. closed 3.34% below its 52-week high of $82.63, which the company achieved on February 27th.
The S&P 500 Index ($SPX) (SPY) today is down -0.28%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.16%, and the ...
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
The S&P 500 Index ($SPX) (SPY) today is down -0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.07%, and the ...
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read ...
In addition to the increased investment, two representatives from KKR will join the Henry Schein board as independent directors. The new directors are expected to provide strategic guidance and ...